BIOCRYST PHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $74.6M | $-13.7M | $-13.5M |
| FY2010 | $62.4M | $-34.4M | $-33.9M |
| FY2011 | $19.6M | $-49.6M | $-56.9M |
| FY2012 | $26.3M | $-33.9M | $-39.1M |
| FY2013 | $17.3M | $-30.7M | $-30.1M |
| FY2014 | $13.6M | $-45.8M | $-45.2M |
| FY2015 | $48.3M | $-39.4M | $-43.0M |
| FY2016 | $26.4M | $-48.6M | $-55.1M |
| FY2017 | $25.2M | $-57.4M | $-65.8M |
| FY2018 | $20.7M | $-94.2M | $-101.3M |
| FY2019 | $48.8M | $-99.5M | $-108.9M |
| FY2020 | $17.8M | $-174.8M | $-182.8M |
| FY2021 | $157.2M | $-177.7M | $-184.1M |
| FY2022 | $270.8M | $-148.4M | $-247.1M |
| FY2023 | $331.4M | $-103.7M | $-226.5M |
| FY2024 | $450.7M | $-2.5M | $-88.9M |
| FY2025 | $874.8M | $341.0M | $263.9M |